A new blood test was found to detect colon cancer with more than 80% accuracy — and to rule it out for 90% of healthy people.

Too much processed meat and not enough fruits and whole grains are the leading risk factors for diet-related GI cancers.

Researchers investigated immune-related adverse effects and characteristics that may predict their incidence in patients receiving ICIs for gastrointestinal cancers.

Researchers explored the link between cancer stage at diagnosis and survival outcomes for non-Hispanic Black patients with gastrointestinal cancers.

Perspective Therapeutics shares interim results for [212Pb]VMT-α-NET trial, showing promising safety, stable disease cases, ...

Opdivo plus chemo showed long-term survival advantages in Chinese patients with advanced gastric, gastroesophageal junction ...

David B. Zhen, MD, discusses the results of the phase 3 CheckMate 649 trial in patients with advanced gastric cancer, ...

In 2024, 6,889 cancer patients visited the institute, up from around 3,500 in 2020, with majority suffering from ...

St. Luke's Hospital is using artificial intelligence (AI) technology that can help doctors find early signs of Colon Cancer.

Bristol Myers Squibb’s Opdivo plus Yervoy, as well as Pfizer’s Braftovi, have each shown strong Phase III performances that ...

Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says.

Men with prostate cancer are living longer than ever, and our goal is to reduce the risk of late toxicities, such as difficulty urinating or rectal bleeding, that can impact a patient’s quality of ...